Related references
Note: Only part of the references are listed.Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer
Sven H. Loosen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Osmotic-controlled release oral tablets: technology and functional insights
Kenneth S. Ogueri et al.
TRENDS IN BIOTECHNOLOGY (2022)
Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression
Michael J. Haas et al.
DRUGS (2022)
Smooth Muscle Cell-Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location
Pinhao Xiang et al.
FRONTIERS IN PHYSIOLOGY (2022)
High-Density Lipoprotein and Cardiovascular Disease-Where do We Stand?
Iulia Iatan et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2022)
New Strategies to Promote Macrophage Cholesterol Efflux
Hong Y. Choi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Plug and Play Functionalized Erythrocyte Nanoplatform for Target Atherosclerosis Management
Yuan Zhong et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study
Fan Luo et al.
LIPIDS IN HEALTH AND DISEASE (2021)
HDL and cancer-causality still needs to be confirmed? Update 2020
Shiva Ganjali et al.
SEMINARS IN CANCER BIOLOGY (2021)
Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis
Hong Y. Choi et al.
FRONTIERS IN PHARMACOLOGY (2021)
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study
Marit A. C. Vermunt et al.
CANCER REPORTS (2021)
Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials
Marit Vermunt et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2021)
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Marteinn Thor Snaebjornsson et al.
CELL METABOLISM (2020)
Synthesis of Taxol and Docetaxel by Using 10-Deacetyl-7-xylosyltaxanes
Baoyu Xue et al.
CHEMISTRY & BIODIVERSITY (2020)
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Lisa M. Butler et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Lipids in the tumor microenvironment: From cancer progression to treatment
Kevin C. Corn et al.
PROGRESS IN LIPID RESEARCH (2020)
Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals
Kasper Monsted Pedersen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Binlu Huang et al.
NATURE METABOLISM (2020)
Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis
Ying Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Changes in lipids composition and metabolism in colorectal cancer: a review
Alicja Pakiet et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model
Bianca C. Meneghini et al.
VASCULAR PHARMACOLOGY (2019)
HDL and Reverse Cholesterol Transport Basic Mechanisms and Their Roles in Vascular Health and Disease
Mireille Ouimet et al.
CIRCULATION RESEARCH (2019)
Pathways of smooth muscle foam cell formation in atherosclerosis
Collin S. Pryma et al.
CURRENT OPINION IN LIPIDOLOGY (2019)
An asymmetrical dual coating on the stent prepared by ultrasonic atomization
Jingjing Wang et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2019)
High-Density Lipoprotein Components and Functionality in Cancer: State-of-the-Art
Shiva Ganjali et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Inhibition of in-stent restenosis after graphene oxide double-layer drug coating with good biocompatibility
Shuang Ge et al.
REGENERATIVE BIOMATERIALS (2019)
Comparative In Vitro Toxicity Study of Docetaxel and Nanoxel, a Docetaxel-Loaded Micellar Formulation Using Cultured and Blood Cells
Van Quan Do et al.
TOXICOLOGICAL RESEARCH (2019)
Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis
Hong Y. Choi et al.
EUROPEAN HEART JOURNAL (2018)
Membrane microdomains and the regulation of HDL biogenesis
Jacques Genest et al.
CURRENT OPINION IN LIPIDOLOGY (2018)
Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends
Muhammad Farhan Sohail et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy
Xin Li et al.
LIPIDS IN HEALTH AND DISEASE (2018)
High density lipoprotein cholesterol and cancer: Marker or causative?
Matted Pirro et al.
PROGRESS IN LIPID RESEARCH (2018)
HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
Emily E. Morin et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management
Hong Y. Choi et al.
CANADIAN JOURNAL OF CARDIOLOGY (2017)
Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases
Yun Wang et al.
ONCOTARGET (2016)
Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells
Monika Sharma et al.
PLOS ONE (2016)
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose
Hirotsugu Kenmotsu et al.
CANCER SCIENCE (2015)
Presentation and management of docetaxel-related adverse effects in patients with breast cancer
Maria Y. Ho et al.
CANCER MANAGEMENT AND RESEARCH (2014)
Insights into the interaction of Discodermolide and Docetaxel with Tubulin. Mapping the Binding Sites of Microtubule-Stabilizing Agents by Using an Integrated NMR and Computational Approach
Angeles Canales et al.
ACS CHEMICAL BIOLOGY (2011)
Vascular Smooth Muscle Cell Proliferation in Restenosis
Steven O. Marx et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I)
Xavier Morelli et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Inhibitory Effects of Docetaxel on Platelet-Derived Growth Factor (PDGF)-BB-Induced Proliferation of Vascular Smooth Muscle Cells Through Blocking PDGF-Receptor β Phosphorylation
Eun Seok Park et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer
E. S. Antonarakis et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses
Mathilde Bayet-Robert et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Small-Molecule Protein-Protein Interaction Inhibitors: Therapeutic Potential in Light of Molecular Size, Chemical Space, and Ligand Binding Efficiency Considerations
Peter Buchwald
IUBMB LIFE (2010)
Smooth Muscle LDL Receptor-Related Protein-1 Inactivation Reduces Vascular Reactivity and Promotes Injury-Induced Neointima Formation
Joshua E. Basford et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
ATP-Binding Cassette Transporter A1 Expression and Apolipoprotein A-I Binding Are Impaired in Intima-Type Arterial Smooth Muscle Cells
Hong Y. Choi et al.
CIRCULATION (2009)
Role of smooth muscle cells in the initiation and early progression of atherosclerosis
Amanda C. Doran et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Optimization of taxane binding to microtubules: Binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel
Ruth Matesanz et al.
CHEMISTRY & BIOLOGY (2008)
Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice
M Van Eck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Clinical pharmalcokinetics of docetaxel - Recent developments
SD Baker et al.
CLINICAL PHARMACOKINETICS (2006)
PDGF and cardiovascular disease
EW Raines
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
LRP: Role in vascular wall integrity and protection from atherosclerosis
P Boucher et al.
SCIENCE (2003)
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
VJ Dzau et al.
NATURE MEDICINE (2002)
Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model
S Yasuda et al.
CARDIOVASCULAR RESEARCH (2002)
Share Paper
